Total revenues for 2025 increased by 6.2% to $3.3 billion, up from $3.1 billion in 2024. Net loss attributable to Surgery Partners, Inc. significantly decreased to $77.9 million in 2025, compared to $168.1 million in 2024. Adjusted EBITDA increased by 3.5% to $526.2 million in 2025, up from $508.2 million in 2024. Same-facility revenues grew by 4.9% in 2025, with a 3.4% increase in case volumes and a 1.4% increase in revenue per case. The company acquired a controlling interest in 12 surgical facilities and several physician practices for $162.1 million cash, net of cash acquired, during 2025. As of December 31, 2025, Surgery Partners owned or operated 176 surgical facilities across 30 states, including 157 ambulatory surgery centers (ASCs) and 19 surgical hospitals. Patient service revenues accounted for 97.5% of total revenues, with private insurance representing 52.3% and government payors 42.8% of patient service revenues in 2025. Orthopedics and pain management remained the largest specialty, accounting for 40.7% of cases in 2025.